Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
A Banner Moment For Alzheimer's Positions Eisai/Biogen At The Head Of The Pack
More Data To Be Reported At CTAD In November
Sep 28 2022
•
By
Mandy Jackson
Lecanemab is the first of three near-term anti-amyloid readouts • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Clinical Trials
More from R&D